Athanor Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,767	Closed	-$364K	–	810
2020 Q4	$364K	Buy	20,767 +179	+0.9%	+$3.14K	0.01%	487
2020 Q3	$305K	Buy	+20,588	New	+$305K	0.01%	406